UA101459C2 - Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1 - Google Patents

Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1

Info

Publication number
UA101459C2
UA101459C2 UAA201205107A UAA201205107A UA101459C2 UA 101459 C2 UA101459 C2 UA 101459C2 UA A201205107 A UAA201205107 A UA A201205107A UA A201205107 A UAA201205107 A UA A201205107A UA 101459 C2 UA101459 C2 UA 101459C2
Authority
UA
Ukraine
Prior art keywords
human recombinant
recombinant interleukin
oral care
care composition
oral
Prior art date
Application number
UAA201205107A
Other languages
English (en)
Russian (ru)
Inventor
Ігор Артурович Петропавлов
Ігор Анатолієвіч Помиткін
Original Assignee
Юнайтед Технолоджіс Ут Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнайтед Технолоджіс Ут Аг filed Critical Юнайтед Технолоджіс Ут Аг
Publication of UA101459C2 publication Critical patent/UA101459C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Винахід стосується складів по догляду за порожниною рота, що містять людський рекомбінантний інтерлейкін-1, і способи їх застосування для підтримання порожнини рота у хорошому стані, зменшення неприємного запаху з порожнини рота і профілактики або лікування захворювань пародонта.
UAA201205107A 2009-09-29 2009-09-29 Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1 UA101459C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/062639 WO2011038754A1 (en) 2009-09-29 2009-09-29 Oral care compositions containing human recombinant interleukin-1

Publications (1)

Publication Number Publication Date
UA101459C2 true UA101459C2 (uk) 2013-03-25

Family

ID=42715271

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201205107A UA101459C2 (uk) 2009-09-29 2009-09-29 Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1

Country Status (10)

Country Link
US (1) US20120219511A1 (uk)
EP (1) EP2464330B1 (uk)
JP (1) JP5661777B2 (uk)
KR (1) KR101533316B1 (uk)
CN (1) CN102573788B (uk)
BR (1) BR112012007399A2 (uk)
EA (1) EA019332B1 (uk)
TW (1) TWI478722B (uk)
UA (1) UA101459C2 (uk)
WO (1) WO2011038754A1 (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9917885B2 (en) 2013-07-30 2018-03-13 International Business Machines Corporation Managing transactional data for high use databases
KR101610861B1 (ko) * 2014-07-28 2016-04-11 (주)케어젠 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도
EP3435961B1 (en) * 2016-03-29 2024-01-03 SafeWhite, Inc. Polyelectrolyte dental adhesives for whitening teeth and teeth components

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1
DE3883252T2 (de) * 1987-12-18 1993-11-25 Immunex Corp Örtliche wundheilmittel, die interleukin-1-proteine enthalten.
US5202118A (en) * 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
ZA89202B (en) * 1988-01-15 1989-09-27 Hoffmann La Roche Recombinant human interleukin-1 alpha polypeptides
EP0644203A1 (en) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. IL-1alpha derivatives and medicament for treating thrombocytopenia
US5827534A (en) * 1995-05-24 1998-10-27 University Of Maryland At Baltimore Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
US6413760B1 (en) * 1997-04-15 2002-07-02 Genetics Institute, Inc. Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
ID20480A (id) * 1997-10-02 1998-12-24 Lg Chemical Ltd Komposisi untuk mencegah atau mengobati penyakit periodontal yang terdiri dari ekstrak dari achyranthis radix atau ulmus cortex
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
JP2002200161A (ja) * 2000-10-24 2002-07-16 Menicon Co Ltd 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20080230298A1 (en) * 2003-09-18 2008-09-25 Robert Michael Buch Method of Applying Oral Compositions
US7279457B2 (en) * 2004-03-12 2007-10-09 Biodel, Inc. Rapid acting drug delivery compositions
ES2356167T3 (es) * 2004-05-03 2011-04-05 Interleukin Genetics, Inc. Método de diagnóstico y terapia para enfermedades asociadas con un haplotipo inflamatorio il-1.
EP1804817A4 (en) * 2004-08-27 2009-11-11 Advanced Viral Res Corp METHODS OF PROMOTING WOUND HEALING
US20080008663A1 (en) * 2006-07-10 2008-01-10 Wm. Wrigley Jr. Company Method of reducing inflammation
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system

Also Published As

Publication number Publication date
TWI478722B (zh) 2015-04-01
WO2011038754A1 (en) 2011-04-07
CN102573788A (zh) 2012-07-11
JP2013505972A (ja) 2013-02-21
EA201200196A1 (ru) 2012-07-30
TW201117823A (en) 2011-06-01
BR112012007399A2 (pt) 2016-08-09
JP5661777B2 (ja) 2015-01-28
KR20120081593A (ko) 2012-07-19
CN102573788B (zh) 2014-05-21
EP2464330A1 (en) 2012-06-20
KR101533316B1 (ko) 2015-07-03
US20120219511A1 (en) 2012-08-30
EP2464330B1 (en) 2016-03-23
EA019332B1 (ru) 2014-02-28

Similar Documents

Publication Publication Date Title
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
ZA200907892B (en) Oral care composition to reduce or eliminate dental sensitivity
ATE511753T1 (de) Postnatale stammzellen und deren verwendungen
MX2011003473A (es) Composiciones para el cuidado bucal.
MY159576A (en) Oral care composition to reduce or eliminate dental sensitivity
BRPI0907102A2 (pt) composição dental, e, método para eliminar ou reduzir o desconforto e a dor associados com a hipersensibilidade da dentina
NZ594056A (en) New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
MX2009012690A (es) Composiciones, metodos, dispositivos y sistemas para el cuidado bucal.
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
MX2009007389A (es) Composiciones paras el cuidado oral que comprende extracto de hippophae.
BR112012015750A2 (pt) composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
BR112013026802A2 (pt) estabilidade de peróxido melhorada em composições de tratamento oral
MX2015007879A (es) Composicion para el cuidado oral.
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
EP1940872A4 (en) PEPTIDES THAT ACTUATE IN THE TREATMENT OF SKIN TREATMENTS OR THE TREATMENT OF PERIODAL DISEASES
MY150931A (en) Substituted oxazolidinones and their use
PL2056787T5 (pl) Kompozycja do pielęgnacji protezy dentystycznej
UA101459C2 (uk) Склад для догляду за порожниною рота, що містить людський рекомбінантний інтерлейкін-1
EP1841444A4 (en) PEPTIDE FORMULATIONS FOR PERIODONTAL AND DENTAL TREATMENTS
IL194353A0 (en) Lysobactin amides
EP2127681A4 (en) THERAPEUTIC AGENT AGAINST PARODONTAL DISEASES AND ALVEOLAR BONE LOSS THROUGH OPERATION
MX2012007035A (es) Composiciones que comprenden alginatos con una alta proporcion de acido guluronico/acido manuronico para usarse en el tratamiento de hipersensibilidad de la dentina.
FR2975292B1 (fr) Utilisation de la kappa-elastine pour la reparation et/ou la regeneration des tissus parodontaux
GB202110114D0 (en) Oral care compositions for use in treaatment